Since the serrated neoplastic pathway has been regarded as an important pathway of colorectal carcinogenesis, few reports have been published on clinical cases of cancer derived from sessile serrated adenoma/polyp, especially on recurrence after resected sessile serrated adenoma/polyp. An elderly woman underwent endoscopic mucosal resection of a flat elevated lesion, 30 mm in diameter, in the ascending colon; the histopathological diagnosis at that time was a hyperplastic polyp, now known as sessile serrated adenoma/polyp. Five years later, cancer due to the malignant transformation of the sessile serrated adenoma/polyp was detected at the same site. The endoscopic diagnosis was a deep invasive carcinoma with a remnant sessile serrated adenoma/polyp component. The carcinoma was surgically removed, and the pathological diagnosis was an adenocarcinoma with sessile serrated adenoma/polyp, which invaded the muscularis propria. The surgically removed lesion did not have a B-RAF mutation in either the sessile serrated adenoma/polyp or the carcinoma; moreover, the initial endoscopically resected lesion also did not have a B-RAF mutation. Immunohistochemistry confirmed negative MLH1 protein expression in only the cancer cells. Lynch syndrome was not detected on genomic examination. The lesion was considered to be a cancer derived from sessile serrated adenoma/polyp recurrence after endoscopic resection, because both the surgically and endoscopically resected lesions were detected at the same location and had similar pathological characteristics, with a serrated structure and low-grade atypia. Furthermore, both lesions had a rare diagnosis of a sessile serrated adenoma/polyp without B-RAF mutation. This report highlights the need for the follow-up colonoscopy after endoscopic resection and rethinking our resection procedures to improve treatment.
Background
In 2003, Torlakovic et al. (1) showed that some hyperplastic polyps (HPs) are neoplastic and proposed the disease entity of sessile serrated adenoma/polyp (SSAP). Following their proposal, serrated polyps (SPs) were classified as classical HPs, SSAPs or traditional serrated adenomas (TSAs) (2) based on detailed pathological analyses. The adenoma-carcinoma sequence proposed by Vogelstein (3) is still the canonical pathway of colorectal carcinogenesis, accounting for ∼80% of all cases of colorectal cancer. Recently, the serrated neoplastic pathway has been thought to play an important role in the carcinogenesis of proximal colorectal cancer (4) . Specifically, B-RAF mutation is observed in the majority of SSAPs, but is almost never observed in conventional adenomas (5) . In addition, SSAP-derived cancers are characterized by a high microsatellite instability (MSI) status. These findings lend support to the existence of the serrated neoplastic pathway and SSAPs being the main precursors of MSI-high colon cancers (6) . The presence of SSAPs should be considered seriously, especially in terms of the treatment indications for SSAPs, and surveillance after endoscopic resection is important as well.
We encountered a thought-provoking case of a cancer coexisting with SSAP in the proximal colon, possibly derived from a residual SSAP with low-to-high grade atypia after endoscopic resection of a lesion diagnosed as an atypical HP 5 years previously.
Case presentation
A 77-year-old woman was referred to our hospital for further management of a flat lesion, ∼30 mm in diameter, in the ascending colon in 2007. The color pattern, transparency and mucinous deposition of the lesion were identical to those of the surrounding mucosa, and HP was diagnosed on the basis of endoscopic findings. Because the lesion was large and located in the proximal colon, we decided to treat the lesion with endoscopic resection. Endoscopic piecemeal mucosal resection (EPMR) was performed, and therefore, the horizontal margin status on histopathology was unclear.
A final diagnosis of a HP with a metaplastic component was made on the basis of the histopathological criteria at that time ( Fig. 1 ). Of note, reliable pathological diagnostic criteria regarding sessile serrated adenomas, including atypical HPs, were not established before the implementation of the new World Health Organization classification in 2010. After treatment, the patient was followed up at a private hospital. At the 1-year follow up after EPMR, no neoplastic lesions were detected. Therefore, the next follow-up examination had been scheduled for 3 years later.
In 2012, 5 years after the initial EPMR, a recurrent lesion was suspected on examination at the same private hospital. It was a flat, elevated lesion with a diameter of 30 mm, located in the ascending colon. The patient was referred again to our hospital for treatment. Conventional endoscopy with indigo carmine dye spraying revealed a large superficial elevated lesion with an elevated area and a depression on the right edge of the lesion (Fig. 2 ). The previous lesion was located in the ascending colon as determined by a common marking of the anal site with 2-folds from cecum ( Fig. 3a ; white arrow at cecum). The trace after initially resection in 2007 was showed Fig. 3b , the recurrent lesion was showed at the same position, ( Fig. 3c ; white arrow at cecum). Moreover, we detected right side convulsions that were considered due to the initial EPMR ( Fig. 3d ; yellow arrow at convulsions). For further examination, narrow-band imaging with magnification was employed to visualize the entire area of the superficial elevated lesion, including the depressed portion ( Fig. 4 ). The intervening area between the superficial and elevated portions showed unclear vessel patterns and expanded crypt openings with magnifying surface patterns, which are frequently seen in SSAPs (7) (Fig. 4b ). In the depressed portion had irregular vessels characterized by disordered capillary networks, which are commonly seen in carcinomas ( Fig. 4c ). According to the classification proposed by Kimura et al. (8) , the pit pattern in the flat area was classified as Type II open that is specific to SSAPs. In contrast, III L -like pits of various sizes with patchy fragmentation (V I -pit pattern) were distributed irregularly in the depressed region inside the elevated area.
Considering all these endoscopic findings, the lesion was considered to be a cancer derived from SSAP that invaded the submucosal layer. Therefore, surgical resection with lymph node dissection was recommended. A laparoscopic right hemi-colectomy was performed without any sequelae, and the final pathological diagnosis was a well-to-moderately differentiated adenocarcinoma with an SSAP component that invaded the muscular layer, T2N0M0, Stage I. The resected specimen had a peculiar gross appearance. The lesion was composed of three different organizations, a flat, elevated and intervening region, which were pathologically examined individually (Fig. 5a ); the pathological diagnoses of the each region were SSAP with low-grade atypia (Fig. 5b) , adenocarcinoma ( Fig. 5c and e) and SSAP with high-grade atypia, respectively (Fig. 5d ).
The loss of MLH1 protein expression was evident by immunohistochemical analysis only in the cancer cells ( Fig. 6) , with the SSAP with low-grade atypia and SSAP with high-grade atypia components showing MLH1 protein expression. We re-examined the initial endoscopic resection specimen obtained 5 years previously. The histopathological diagnosis was SSAP with low-grade atypia, with MLH1 protein expression in those parts. The MSI status and K-RAS/B-RAF mutation status were analyzed using DNA samples extracted from microdissected tumor cells in each region. In the surgical resected specimen, the cancer derived from SSAP showed positive expression of four of the five MSI markers, indicating an MSI-high status. K-RAS or B-RAF mutations were not identified in any of the regions (Fig. 7) . Similarly, the specimen that was endoscopically resected 5 years previously did not show B-RAF mutation. On the basis of genomic examination performed after obtaining informed consent, the absence of Lynch syndrome was confirmed.
Discussion
Since carcinogenesis from SPs via the serrated neoplastic pathway has been reported (5), it has become necessary to distinguish the features of classical HP, SSAP and TSA. Furthermore, it is important to standardize the endoscopic and histopathological diagnostic criteria for these lesions to accurately evaluate the malignant potential of each subtype. In previous studies, the B-RAF mutation has been detected in 65-90% of SSAPs, which is a significantly higher rate than that for other SPs (5, 9, 10) . In addition, the B-RAF mutation was detected more often in SSAPs located in the proximal colon, suggesting an effect of location on tumor development (9, 11) .
In the present case of cancer coexisting with SSAP located in the proximal colon, B-RAF mutations were not detected in any of the specimens examined. Pathological examination showed continuous gradation of the SSAP area to the cancerous portions, without any traditional adenomatous components. Furthermore, the grading of the serrated structure, such as low-grade atypia, of the initially resected lesion was similar to that of the surgically resected lesion. Loss of MLH1 protein expression was observed in only the cancer cells. Moreover, a MSI-high status was confirmed for the cancer. B-RAF mutation status in sporadic and familial MSI-high colorectal cancers has been shown to differ. Familial MSI-high lesions such as Lynch syndrome are associated with an earlier age of onset and histopathological characteristics that reflect an origin in traditional adenoma (12) . Moreover, some reports state that familial MSI-high colorectal cancers do not show B-RAF mutation (13) . In the present case, B-RAF mutation was not detected in the MSI-high colorectal cancer in the proximal colon, but cancer was diagnosed at an advanced age. Finally, on the basis of genetic sequencing results, Lynch syndrome was ruled out. In conclusion, we consider that the lesion in this case is a sporadic MSI-high colorectal cancer. Thus, the SSAP in this case was rare.
The sporadic MSI-high cancer developed from a recurrent SSAP without B-RAF mutation, which arose from a SSAP without B-RAF mutation that was endoscopically resected with microscopic residual organs. We hypothesize that the SSAP without B-RAF mutation was localized for a long period; transformation occurred in the recurrent lesion, seen on the right edge of the presented lesion; and carcinoma then developed rapidly from the SSAP.
Our resection procedures need to be re-thought to improve treatment and decrease the rate of SSAP recurrence. Currently, the treatment strategy for SSAPs with a diameter of >20 mm is not established. Furthermore, the recurrence rate of SSAPs after endoscopic resection has not been reported. For colorectal neoplastic lesions, including adenomatous lesions of all pathological types, the recurrence rate after piecemeal resection such as EPMR has been reported to be higher than that after en bloc resection (14, 15) . Pohl et al. (16) reported that the rate of incomplete resection was significantly associated with tumor size and SSAP histology, as margins of very large SSAPs are often not distinct. To decrease the recurrence rate, we recommend resected margin examination with magnifying endoscopy; however, the resected margin immediately after EPMR is often not clearly observed. Therefore, a special process should be considered for SSAP resection, which could involve marking the edge of the SSAP before resection, coagulating the margin after resection or confirming scar formation over a short-term follow-up after resection, with additional treatment as needed (17, 18) . If these measures are difficult to implement, we ought to select en bloc resection with procedures such as endoscopic submucosal dissection and, rather important thing is to detect the SSAP should be complete resection.
During surveillance after SSAP resection, if resection is found to be incomplete or the status cannot be determined, follow-up colonoscopy could be recommend once within a year (19) . The appropriate intervals for surveillance are still debated, as the growth process of SSAPs is uncertain-whether SSAPs spread laterally over time or have clear borders and appear rapidly is still not established. According to the study by Holme et al. (20) large SPs left in situ do not frequently progress to colorectal cancer over their natural course and large serrated polyps are an independent risk factor for colorectal cancer. The rate of growth of SSAP may be slow, but this is not related with its malignant potential. We should pay careful attention to the possibility that SSAP recurrence from residual lesion is also undergo malignant transformation similar to those of conventional adenoma.
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